Royce & Associates LP acquired a new stake in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 3,151 shares of the technology company's stock, valued at approximately $493,000.
A number of other institutional investors have also recently made changes to their positions in the company. Quarry LP grew its holdings in Plexus by 573.5% during the 3rd quarter. Quarry LP now owns 229 shares of the technology company's stock valued at $31,000 after buying an additional 195 shares in the last quarter. R Squared Ltd bought a new position in shares of Plexus during the 4th quarter valued at approximately $45,000. Point72 DIFC Ltd purchased a new position in shares of Plexus in the third quarter valued at $51,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in Plexus in the third quarter worth $55,000. Finally, USA Financial Formulas purchased a new stake in Plexus during the fourth quarter valued at $56,000. Hedge funds and other institutional investors own 94.45% of the company's stock.
Insider Activity
In other news, Director Randy J. Martinez sold 887 shares of Plexus stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $140.52, for a total transaction of $124,641.24. Following the completion of the sale, the director now owns 4,831 shares of the company's stock, valued at approximately $678,852.12. The trade was a 15.51 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Todd P. Kelsey sold 1,500 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $156.39, for a total value of $234,585.00. Following the completion of the transaction, the chief executive officer now directly owns 74,271 shares in the company, valued at approximately $11,615,241.69. This trade represents a 1.98 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 19,458 shares of company stock valued at $2,786,515. 1.76% of the stock is currently owned by company insiders.
Plexus Trading Down 1.4 %
NASDAQ:PLXS traded down $1.88 during mid-day trading on Wednesday, hitting $130.24. 116,225 shares of the stock traded hands, compared to its average volume of 151,990. The company has a quick ratio of 0.70, a current ratio of 1.53 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 52 week low of $90.87 and a 52 week high of $172.89. The stock has a market capitalization of $3.52 billion, a price-to-earnings ratio of 30.22 and a beta of 0.90. The firm's 50 day moving average is $138.83 and its two-hundred day moving average is $145.87.
Plexus (NASDAQ:PLXS - Get Free Report) last released its earnings results on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing analysts' consensus estimates of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. On average, equities research analysts predict that Plexus Corp. will post 5.9 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on the stock. Benchmark restated a "buy" rating and issued a $165.00 target price on shares of Plexus in a report on Wednesday, January 22nd. Needham & Company LLC upped their price objective on Plexus from $162.00 to $172.00 and gave the company a "buy" rating in a research report on Friday, January 24th. Finally, Stifel Nicolaus started coverage on Plexus in a report on Tuesday, February 4th. They issued a "hold" rating and a $152.00 target price for the company. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Plexus presently has an average rating of "Moderate Buy" and an average price target of $163.00.
Check Out Our Latest Stock Analysis on Plexus
About Plexus
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More

Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.